The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of irinotecan monotherapy as third line treatment for advanced gastric cancer.
 
Takeshi Kawakami
No Relationships to Disclose
 
Nozomu Machida
No Relationships to Disclose
 
Masahiro Kawahira
No Relationships to Disclose
 
Sadayuki Kawai
No Relationships to Disclose
 
Yosuke Kito
No Relationships to Disclose
 
Yukio Yoshida
No Relationships to Disclose
 
Satoshi Hamauchi
No Relationships to Disclose
 
Takahiro Tsushima
No Relationships to Disclose
 
Akiko Todaka
Consulting or Advisory Role - Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
 
Kentaro Yamazaki
Speakers' Bureau - Daiichi Sankyo; Yakult Pharmaceutical
 
Tomoya Yokota
Honoraria - Merck Serono
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono
 
Akira Fukutomi
Honoraria - Daiichi Sankyo; Lilly Japan; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Yakult Honsha
Research Funding - GlaxoSmithKline (Inst); Merck Serono (Inst); OncoTherapy Science (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Teijin Pharma (Inst); Yakult Honsha (Inst)
 
Yusuke Onozawa
No Relationships to Disclose
 
Hirofumi Yasui
No Relationships to Disclose